Eli Lilly Unveils Q1 2025 Financial Results, Showcases Strong Pipeline Progress
Eli Lilly Reports Strong Q1 2025 Financial Results, Driven by Surging Demand for Mounjaro and Zepbound, While Advancing Pipeline Innovations Eli Lilly and Company (NYSE: LLY) has delivered a robust…
Vaccine Study Shows Fewer Side Effects with PharmaJet Needle-Free Delivery
Vaccine Study Shows Fewer Side Effects with PharmaJet Needle-Free Delivery PharmaJet®, a company committed to advancing the performance, safety, and effectiveness of injectable vaccines and therapies through innovative needle-free injection…
AI-Driven HSS Study Identifies Risk Factors for Severe Pain After Knee Replacement
AI-Driven HSS Study Identifies Risk Factors for Severe Pain After Knee Replacement At the 50th Annual Meeting of the American Society of Regional Anesthesia and Pain Medicine (ASRA), a groundbreaking…
PrimaryOne Health and AndHealth Cut Ribbon on New Retail & Specialty Pharmacy to Enhance Community Medication Access
PrimaryOne Health and AndHealth Cut Ribbon on New Retail & Specialty Pharmacy to Enhance Community Medication Access PrimaryOne Health, in partnership with AndHealth, proudly celebrated the grand opening of its…
New SURPASS-3 Data Links Tirzepatide to Muscle Composition Changes in Type 2 Diabetes
New SURPASS-3 Data Links Tirzepatide to Muscle Composition Changes in Type 2 Diabetes In an increasingly dynamic and rapidly evolving field of metabolic disease management, the nuanced effects of weight…
Bio-Rad Announces Financial Results for the First Quarter of 2025
Bio-Rad Announces Financial Results for the First Quarter of 2025 Bio-Rad Laboratories, Inc. , a global leader in life science research and clinical diagnostics, released its financial results for the…
Crown Bioscience and NEXT Oncology Expand Strategic Partnership
Crown Bioscience and NEXT Oncology Expand Strategic Partnership In a significant development that reinforces their shared vision for transforming cancer research and drug development, Crown Bioscience, a global contract research…
Genmab to Submit sBLA to FDA for Epcoritamab Combo in Relapsed/Refractory Follicular Lymphoma
Genmab to Submit sBLA to FDA for Epcoritamab Combo in Relapsed/Refractory Follicular Lymphoma Genmab A/S, a leading international biotechnology company specializing in the development of antibody therapeutics for the treatment…
PCI Pharma Acquires Ajinomoto Althea as Part of $1B Investment to Boost U.S. Aseptic Fill-Finish Capacity
PCI Pharma Acquires Ajinomoto Althea as Part of $1B Investment to Boost U.S. Aseptic Fill-Finish Capacity PCI Pharma Services, a globally recognized contract development and manufacturing organization (CDMO) specializing in…
Sapient Unveils DynamiQ Next-Gen Data Insights Engine for Drug Discovery and Development
Sapient Unveils DynamiQ Next-Gen Data Insights Engine for Drug Discovery and Development Sapient, a pioneering leader in multi-omics data generation and clinical insights, has unveiled its next-generation multi-omics and real-world…
Predicta Biosciences Unveils First Molecular Diagnostic for Enhancing Multiple Myeloma Prognosis
Predicta Biosciences Unveils First Molecular Diagnostic for Enhancing Multiple Myeloma Prognosis Predicta Biosciences, a precision oncology company, has officially launched its first Laboratory Developed Test (LDT), GenoPredicta, a cutting-edge diagnostic…
Verily Wins Michael J. Fox Foundation Grant to Build Major Parkinson’s Molecular Dataset
Verily Wins Michael J. Fox Foundation Grant to Build Major Parkinson’s Molecular Dataset In a significant development for neurodegenerative disease research, Verily, the Alphabet-owned precision health technology company, announced today…